Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1991
12/14/1991WO1991019745A1 Chimeric toxins with improved inter-domain geometry
12/14/1991WO1991019494A1 Compositions for treating hiv-type 1 infection
12/14/1991CA2085234A1 Compositions for treating hiv-type 1 infection
12/14/1991CA2083487A1 Chimeric toxins with improved inter-domain geometry
12/14/1991CA2043497A1 Crystalline polypeptides
12/14/1991CA2043463A1 Synergistic antimicrobial compositions
12/13/1991CA2085245A1 Aminosteroids for ophthalmic use
12/13/1991CA2044333A1 Chemotherapeutic agents
12/13/1991CA2044191A1 Process for the purification of factor viii and factor viii obtained by said process
12/12/1991WO1991019739A1 Multivalent antigen-binding proteins
12/12/1991WO1991019725A2 Heterocyclic anthracyclione and anthracycline analogs
12/12/1991WO1991019498A1 Treatment of organ transplantation rejection
12/12/1991WO1991019010A1 Method and probes for detection of alport syndrome
12/12/1991WO1991019009A1 The ciliary neurotrophic factor receptor
12/12/1991WO1991019007A1 Dna sequences involved in neuronal degeneration, multicellular organisms containing same and uses thereof
12/12/1991WO1991018999A1 Yeast-derived epidermal growth factor/urogastrone-like products
12/12/1991WO1991018984A2 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi
12/12/1991WO1991018982A1 Type ii interleukin-1 receptors
12/12/1991WO1991018981A2 Neurotropic growth factors comprising a homeobox peptide
12/12/1991WO1991018928A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i (hiv-1) gp120 and methods of use
12/12/1991WO1991018926A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE
12/12/1991WO1991018924A1 Mammalian adipogenic factors
12/12/1991WO1991018923A1 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
12/12/1991WO1991018913A1 Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna
12/12/1991WO1991018629A1 Method for modulating self-destruction of cytolytic lymphocytes
12/12/1991WO1991018628A1 Therapy and prophylaxis of autoimmune diseases
12/12/1991WO1991018625A1 Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna
12/12/1991WO1991018624A1 Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna
12/12/1991WO1991018622A1 Wound healing
12/12/1991WO1991018621A1 The combination of growth hormone and insulin-like growth factor-i enhances growth
12/12/1991WO1991018620A1 Stimulation of bone marrow stromal and progenitor cells
12/12/1991WO1991018619A1 Apo ai polypeptides, antibodies, and immunoassays
12/12/1991WO1991018611A1 Diagnosis and treatment of viral hepatitis
12/12/1991WO1991018610A1 New use of glucose and a new solution of glucose
12/12/1991WO1991015512A3 Hiv envelope polypeptides
12/12/1991WO1991008291A3 Latency associated peptide and uses therefor
12/12/1991CA2085120A1 Heterocyclic anthracyclinone and anthracycline analogs
12/12/1991CA2085002A1 Treatment of organ transplantation rejection
12/12/1991CA2084062A1 Mammalian adipogenic factors
12/12/1991CA2083603A1 Diagnosis and treatment of viral hepatitis
12/12/1991CA2064829A1 Multivalent antigen-binding proteins
12/12/1991CA2064752A1 Antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi
12/12/1991CA2044201A1 Inactive precursor forms of ribosome inactivating proteins, a process for making and a method of using
12/12/1991CA2043861A1 Peptide oxytocin antagonists
12/12/1991CA2042868A1 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates
12/12/1991CA2042526A1 Method for preventing a second heart attack employing an hmg coa reductase inhibitor
12/11/1991EP0460910A2 Tumor cell growth inhibitor
12/11/1991EP0460846A1 Type II interleukin-1 receptors
12/11/1991EP0460753A2 New Antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi
12/11/1991EP0460720A2 A method of extruding liposomes
12/11/1991EP0460679A2 Endothelin antagonistic peptide derivatives
12/11/1991EP0460607A2 Novel monoclonal antibody to novel antigen associated with human tumors
12/11/1991EP0460448A2 Use of C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin against bacteria resistant to glycopeptide antibiotics
12/11/1991EP0460232A1 Tumor cell growth inhibitor
12/11/1991EP0460189A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
12/11/1991EP0460161A1 Fibroblast growth factor for use in the prevention and treatment of viral infections
12/11/1991EP0460101A1 Immobilized cytokines
12/11/1991EP0460100A1 Liposome gel composition and method
12/11/1991EP0460072A1 Human elastase inhibitor
12/11/1991EP0460064A1 Therapeutic aerosol formulations
12/11/1991EP0460058A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders
12/11/1991EP0460052A1 Il-1 biological activity inhibitors
12/11/1991EP0235187B1 Polypeptides and antibodies characteristic of the papillomavirus, methods of diagnosis and vaccines in which they are used
12/11/1991CN1056812A Pharmaceutical preparation
12/10/1991US5071964 Having phosphatidylinositol lipid anchor; inhibit adhesion of T-cells to other lymphocytes by binding to them
12/10/1991US5071963 Interferon-induced human (2'-5') oligo a synthetase
12/10/1991US5071962 Detection; vaccine against chlamydia infection
12/10/1991US5071961 Adsorption on alpha-hydroxyaminopropyl-modified adsorber, then elution
12/10/1991US5071959 Novel lymphokine for suppressing platelet activation
12/10/1991US5071958 Removal of soft tissue; application of a low molecular weight protein fraction of enamel matrix; joining with living mineralized tissue
12/10/1991US5071957 Antibiotic BU-4061T
12/10/1991US5071956 Glycoproteins for treating vision defects, arthritis, cardiovascular disorders, tumors and rheumatic dieseases
12/10/1991US5071955 Octopeptide exhibiting antimypertensive activity
12/10/1991US5071867 Treatment of chronic kidney disease with angiotensin I converting enzyme inhibitor
12/10/1991US5071837 Novel renin inhibiting peptides
12/10/1991US5071836 Competitive gonadoliberin antagonists
12/10/1991US5071835 Ribonucleotide reductase inhibitors
12/10/1991US5071834 Purified activin B composition
12/10/1991US5071761 Dna sequence coding for human lymphoblastoid interferons
12/10/1991US5071655 Pharmaceutical combination for treatment of bone-wasting diseases
12/10/1991US5071649 Blockage prevention in catheters; mixing ethylene oxide-propylene oxide copolymers with fluid to be delivered
12/07/1991WO1991018623A1 Recombinantly produced lipases for therapeutical treatment
12/07/1991WO1991018617A1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
12/07/1991CA2084184A1 Recombinantly produced lipases for therapeutical treatment
12/07/1991CA2044028A1 Cyclosporine metabolites
12/06/1991CA2043951A1 Monoclonal antibody to novel antigen associated with human tumors
12/05/1991WO1991018927A1 Method for preparing interferon alpha-2 crystals
12/05/1991CA2084406A1 Method for preparing interferon alpha-2 crystals
12/04/1991EP0459795A1 Oral dosage form of biologically active proteins
12/04/1991EP0459788A2 Modified proteins and methods of producing same
12/04/1991EP0459779A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use
12/04/1991EP0459747A1 Precursor forms of porcine growth hormone releasing factor and related DNA compounds
12/04/1991EP0459630A2 Polypeptides
12/04/1991EP0459624A2 Galactosamine-substituted poly-omega-substituted-L-glutamic and/or-aspartic acid
12/04/1991EP0459577A2 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors
12/04/1991EP0459516A1 Oral dosage form of biologically active proteins
12/04/1991EP0459465A2 HIV-protease inhibitors and process for their preparation
12/04/1991EP0459453A2 Use of pravastatin for preventing onset of restenosis after angioplasty
12/04/1991EP0459318A2 Method for preventing onset of restenosis after angioplasty employing an ACE inhibitor
12/04/1991EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
1 ... 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 ... 3163